Mindestbestellung 120 EUR Kostenlose Lieferung ab 250 EUR Bereit zur Abholung dead drop: in 5 Min. abholen Kostenloser Versand ab 250 EUR Aktionen

Substanzen · Phenethylamin-Derivate

2-FMA

C10H14FN CAS 1017176-48-5 Nur für analytische Forschungszwecke — nicht für den menschlichen Verzehr
Bevorzugter Name
2-FMA
IUPAC-Name
1-(2-fluorophenyl)-N-methylpropan-2-amine
CAS-Nummer der Stammverbindung (Referenz)
1017176-48-5
Summenformel
C10H14FN
Molekulargewicht
167.22 g/mol
InChIKey
XNWIKJYFOIDUGD-UHFFFAOYSA-N
PubChem
CID 24257263
Quelle
PubChem
Geprüfte Synonyme und Katalogkürzel
2-Fluoromethamphetamine 2FMA 2 FMA

Passende Artikel im aktuellen Shop-Katalog

Geprüftes Pharmakologie- & Toxikologie-Dossier

2-FMA

Stimulant (dopamine/norepinephrine releaser, low serotonin) Ring-fluorinated methamphetamine (ortho-fluoro)
Geprüfte PubChem- & CAS-Identität C10H14FN · CAS 1017176-48-5 · CID 24257263
Kalibrierte Lieferform Reines Kristall / Analyse-Pulver (≥98 %)
≥98 % analytische Reinheit geprüft 167.22 g/mol
WHO-, PubMed- & PubChem-Quellen 2 cited records

Rezeptor-Telemetrie & Wirkmechanismus

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

2-FMA is the ortho-fluoro analogue of methamphetamine and the N-methyl homologue of 2-FA. Published human transporter numbers are sparse. The observed profile is a long, functional dopamine/norepinephrine stimulant with little serotonergic warmth: focus, wakefulness, appetite loss, and a flat mood rather than an MDMA-like roll. It is less mood-elevating than 3-FA or 4-FA and much less entactogenic than 4-FMA.

Biotransformation & Active Metabolites

Presumed to undergo typical amphetamine N-demethylation and oxidative deamination. It is not a prodrug of 2-FA in any quantitative brackets sense, and a 2-FA oral chart (common 30–50 mg, 2–4 hours) does not describe this longer compound.

Zeitliche Pharmakokinetik

Long, clear, low-elevated dopaminergic tone stimulant. Wakefulness and task focus with vasoconstriction and a hard offset, not an entactogen.

  1. Onset 30–60 minutes
  2. Peak Window 2.5–4 hours
  3. Total Window 7–9 hours
  4. Residual / Half-Life Residual stimulation 4–12 hours. A formal human half-life is not published; the practical problem is next-night insomnia.

Oral threshold 5 mg, light 5–15 mg, common 15–30 mg, strong 30–50 mg, heavy above 50 mg. The total course is 7–9 hours with 4–12 hours of after-effects. A second dose taken to extend the afternoon lands in the insomnia window.

Quantitatives Wirkungsspektrum (Literaturdaten)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
5 mg
Cognitive & Sensory

Slight wakefulness and a cleaner attention span.

Somatic & Autonomic

Mild appetite loss and a small pulse increase.

Light
5–15 mg
Cognitive & Sensory

Functional alertness, motivation, and little emotional color.

Somatic & Autonomic

Dry mouth, cold fingers, and suppressed hunger.

Common Reference
15–30 mg
Cognitive & Sensory

Sustained focus, talkativeness without much elevated dopaminergic tone, and a forced wakefulness that outlasts the useful part.

Somatic & Autonomic

Tachycardia, blood-pressure rise, bruxism, and sweating.

Strong
30–50 mg
Cognitive & Sensory

Scattered focus, irritability, and stimulant anxiety replacing the 'clean' feeling.

Somatic & Autonomic

Pronounced vasoconstriction, tremor, urinary hesitation, and a long inability to sleep.

Heavy / Toxic Zone
50 mg+
Cognitive & Sensory

Agitation, paranoia, and compulsive repeated exposure thoughts.

Somatic & Autonomic

Hypertensive strain, chest tightness, severe insomnia, and seizure risk with tramadol or an MAOI.

Wechselwirkungsmatrix — Niemals kombinieren

Lebensgefahr — Niemals kombinieren

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.

25x-NBOMe and 25x-NBOH

Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.

Tramadol and DXM

Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.

Hohes Risiko — Vermeiden

Other stimulants, cocaine, and high-dose caffeine

Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.

Alcohol, opioids, and benzodiazepines

The stimulant hides sedation. When it drops, the depressant remains.

Vorsicht / Abschwächung

Cannabis

Often increases heart rate and paranoid thought on the offset.

SSRIs and SNRIs

Blunt the serotonergic portion of entactogen-type members while the cardiovascular load stays. They are not protection against serotonin toxicity.

Isomeren- & Strukturvergleich

2-FMA is the long functional fluoro stimulant: common 15–30 mg oral and 7–9 hours, little serotonin. 4-FMA (common 50–100 mg) is more entactogenic and more concerning for the heart. 3-FA (common 30–50 mg, 4–6 hours) is more classically mood-elevating and dopaminergic. 4-FA becomes entactogenic only around 100 mg and has a stroke signal above the strong band. None of those oral numbers are interchangeable.

Stabilität & Lagerung

Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.

Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.

Cross-Tolerance & Dependence Profile

Dopaminergic stimulant tolerance builds with repeated days, halves over roughly 3–7 days, and approaches baseline in 1–2 weeks, with cross-tolerance to amphetamines and other catecholamine stimulants. Psychological dependence and crash fatigue are the dependence pattern. It does not reset serotonin the way an MDMA weekend does, but daily use still produces a flat, vasoconstricted insomnia cycle.

Analytische & toxikologische Monographie

2-FMA (1-(2-fluorophenyl)-N-methylpropan-2-amine; CAS 1017176-48-5, PubChem CID 24257263) is the ortho-fluorinated methamphetamine supplied as pure powder or crystals (C10H14FN, 167.22 g/mol). It behaves as a long dopamine/norepinephrine stimulant with little serotonergic warmth. PsychonautWiki oral bands are threshold 5 mg, light 5–15 mg, common 15–30 mg, strong 30–50 mg, and heavy above 50 mg. Onset is 30–60 minutes and the total course is 7–9 hours, followed by 4–12 hours of residual wakefulness. It is not 4-FMA, not the shorter 3-FA, and not 4-FA. Do not combine with MAOIs, tramadol, other stimulants, or 25x-NBOMe.

Chemische Struktur und Molekülprofil

2-FMA (1-(2-fluorophenyl)-N-methylpropan-2-amine) ist eine Referenzverbindung aus der Stoffklasse Phenethylamin-Derivate mit der Summenformel C10H14FN und einer molaren Masse von 167.22 g/mol. Die Stammverbindung wird unter der CAS-Nummer 1017176-48-5 sowie in der NCBI-PubChem-Datenbank unter CID 24257263 geführt (Standard-InChIKey: XNWIKJYFOIDUGD-UHFFFAOYSA-N). Diese Verbindung teilt ihre Summenformel (C10H14FN) mit Konstitutions- oder Positionsisomeren; die eindeutige Identifizierung erfolgt über den vollständigen IUPAC-Namen und die CAS-Nummer (1017176-48-5).

Quellen

Referenztoxikologie und Sicherheitsprofil

Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört 2-FMA zur chemischen Klasse Amphetamine, Substituted amphetamines. Toxikologische Hinweise (PsychonautWiki): die genaue toxische Schwelle ist in der Fachliteratur nicht festgelegt. Abhängigkeitspotenzial (PsychonautWiki): mäßiges Abhängigkeitspotenzial bei wiederholter Exposition. Dokumentierte Kreuztoleranz: dopamine, stimulant. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.

Quellen

Analytischer Verwendungszweck und Laborhinweis

Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.

Quellen

Dokumentierte Wechselwirkungen und Kontraindikationen

Hohes Risiko / Gefährliche Kombinationen

Unsichere Kombinationen (erhöhtes Risiko)

Ungeklärte Wechselwirkungen (Vorsicht geboten)